Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience

Chimeric antigen receptor (CAR) T-cell therapy is effective in relapsed/refractory large B-cell lymphoma and results in a unique toxicity profile, namely cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome. The hyper-inflammatory state associated with these toxicities has been suggested to increase the risk of thrombosis.
We conducted a retrospective analysis of patients treated with axicabtagene ciloleucel (axi-cel) to assess the rate of thrombosis with axi-cel therapy from the time of CAR T-cell infusion until the end of hospitalization, when performed in the inpatient setting, or up to day +30 when performed in the outpatient setting. Ninety-two (95%) of 97 patients were hospitalized during axi-cel therapy and 85 (88%) developed CRS. Fifty-five patients (57%) received concurrent anticoagulation (53 as prophylaxis). Patients with prior VTE did not have progression https://joplink.net/antigens/ or evidence of new VTE. Only 2 (2.1%) patients developed VTE. These results demonstrate a low-risk for thrombosis in axi-cel recipients.

The Protective Action of Piperlongumine Against Mycobacterial Pulmonary Tuberculosis in Its Mitigation of Inflammation and Macrophage Infiltration in Male BALB/c Mice

Introduction: Piperlongumine (PL) is a bioactive alkaloid and medicinal compound of piperamide isolated from the long pepper (Piper longum Linn). It has demonstrated bactericidal action against Mycobacterium tuberculosis (MTB), the cause of pulmonary tuberculosis; nevertheless, immunomodulatory activity had not been identified for it in MTB-triggered granulomatous inflammation. This study investigated if piperlongumine could inhibit such inflammation.
Material and methods: Mycobacterium tuberculosis strain H37Rv was subjected to a broth microdilution assay. Piperlongumine at 5, 15, and 25 μg/mL, 0.2% dimethyl sulphoxide as control or 4 μM of dexamethasone were tested in vitro on MH-S murine alveolar macrophages. BALB/c mice were orally administered PL at 50, 100 and 150 mg/kg b.w. after trehalose-6,6-dimycolate (TDM) stimulation.
Chemokine and cytokine concentrations were determined in lung supernatants. Flow cytometry and Western blot analysis were performed to determine phosphorylated spleen tyrosine kinase (Syk), c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways.
Results: Piperlongumine inhibited inflammatory mediators and adherence of lymphocyte function-associated antigen 1 to MH-S cells following TDM activation. It also improved macrophage clearance of MTB. In TDM-stimulated MH-S cells, PL significantly influenced the macrophage inducible Ca2+-dependent lectin receptor (Mincle)-Syk-ERK signalling pathway. Oral dosing of PL effectively suppressed the development of pulmonary granulomas and inflammatory reactions in the TDM-elicited mouse granuloma model.

Prevalence of Toxoplasma Gondii in Retail Fresh Meat Products from Free-range Chickens in Spain

Toxoplasma gondii is one of the most prevalent zoonotic protozoan parasites worldwide and affects the vast majority of warm-blooded animal species, including humans. Postnatal infection in humans occurs through the ingestion of sporulated T. gondii oocysts or via the oral intake of parasite tissue cysts during the consumption of raw or undercooked meat. In this regard, given their high exposure to oocysts, chickens (Gallus domesticus) raised on the ground constitute a potential source of T. gondii.
Material and methods: For the first time in Spain, a survey was undertaken in commercial retail free-range poultry. A total of 50 thighs from different animals were analysed. The samples were homogenised and an acid pepsin digestion procedure was applied prior to molecular analysis. Toxoplasma gondii DNA was isolated from meat by qPCR. Two sets of primers were used for DNA amplification targeting the specific sequence of a 529 bp repeat element and another set of primers was utilised for the surface antigen protein-1 gene.

Interrelationships between amphiregulin, kisspeptin, FSH and FSH receptor in promotion of human ovarian cell functions

The aim of this study was to investigate: (1) the ability of granulosa cells to produce amphiregulin (AREG), kisspeptin (KISS) and FSH receptor (FSHR); (2) the role of AREG and KISS in the control of ovarian functions; (3) the effect of FSH and KISS on AREG; and (4) the ability of KISS to affect FSHR and to modify FSH action on AREG output by human ovarian granulosa cells. We examined: (1) time-dependent accumulation of AREG; (2) effects of AREG (0, 1, 10, 100ng/mL) and KISS (0, 1, 10, 100ng/mL) on granulosa cell functions; and (3) the effects of KISS (0, 1, 10, 100ng/mL), FSH (0, 1, 10, 100ng/mL), and their combinations on AREG release.
Viability, markers of proliferation [accumulation ofproliferating cell nuclear antigen (PCNA) cyclin B1 and sodium 3′-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy6-nitro)benzene sulfonic acid hydrate (XTT formazan)] and apoptosis (accumulation of bax, caspase 3 and terminal deoxynucleotidyl transferase dUTP nick-end labelling), accumulation of KISS, FSHR and steroid hormones, and AREG release were analysed by Trypan blue exclusion test, quantitative immunocytochemistry, XTT, terminal deoxynucleotidyl transferase dUTP nick-end labelling assays and enzyme-linked immunosorbent assay.
AREG promoted cell viability, proliferation and steroid hormone output, and inhibited apoptosis. KISS (1 and 10ng/mL) stimulated viability, proliferation, steroid hormone release and occurrence of FSHR and suppressed apoptosis and AREG output; KISS (100ng/mL) had the opposite effect. FSH stimulated AREG release, whilst addition of KISS reversed this FSH effect. FSH mimicked and promoted the inhibitory effect of KISS on AREG release. These results suggest an intra-ovarian production and a functional interrelationship between AREG, KISS, FSH and FSHR in direct regulation of basic ovarian cell functions.

Novel PE and APC tandems: Additional near-infrared fluorochromes for use in spectral flow cytometry

Recent advances in flow cytometry instrumentation and fluorochrome chemistries have greatly increased fluorescent conjugated antibody combinations that can be used reliably and easily in routine experiments. The Cytek Aurora flow cytometer was first released with three excitation lasers (405, 488, and 640 nm) and incorporated the latest Avalanche Photodiode (APD) technology, demonstrating significant improvement in sensitivity for fluorescent emission signals longer than 800 nm.
However, there are limited commercially available fluorochromes capable of excitation with peak emission signals beyond 800 nm. To address this gap, we engineered six new fluorochromes: PE-750, PE-800, PE-830 for the 488 nm laser and APC-750, APC-800, APC-830 for the 640 nm laser.
Utilizing the principal of fluorescence resonance energy transfer (FRET), these novel structures were created by covalently linking a protein donor dye with an organic small molecule acceptor dye. Additionally, each of these fluorochrome conjugates were shown to be compatible with fixation/permeabilization buffer reagents, and demonstrated acceptable brightness and stability when conjugated to antigen-specific monoclonal antibodies. These six novel fluorochrome reagents can increase the numbers of fluorochromes that can be used on a spectral flow cytometer.

Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis

Autoimmune and paraneoplastic encephalitides represent an increasingly recognized cause of devastating human illness as well as an emerging area of neurological injury associated with immune checkpoint inhibitors. Two groups of antibodies have been detected in affected patients. Antibodies in the first group are directed against neuronal cell surface membrane proteins and are exemplified by antibodies directed against the N-methyl-D-aspartate receptor (anti-NMDAR), found in patients with autoimmune encephalitis, and antibodies directed against the leucine-rich glioma-inactivated 1 protein (anti-LGI1), associated with faciobrachial dystonic seizures and limbic encephalitis. Antibodies in this group produce non-lethal neuronal dysfunction, and their associated conditions often respond to treatment.
  • Antibodies in the second group, as exemplified by anti-Yo antibody, found in patients with rapidly progressive cerebellar syndrome, and anti-Hu antibody, associated with encephalomyelitis, react with intracellular neuronal antigens.
  • These antibodies are characteristically found in patients with underlying malignancy, and neurological impairment is the result of neuronal death. Within the last few years, major advances have been made in understanding the pathogenesis of neurological disorders associated with antibodies against neuronal cell surface antigens.
  • In contrast, the events that lead to neuronal death in conditions associated with antibodies directed against intracellular antigens, such as anti-Yo and anti-Hu, remain poorly understood, and the respective roles of antibodies and T lymphocytes in causing neuronal injury have not been defined in an animal model.
  • In this review, we discuss current knowledge of these two groups of antibodies in terms of their discovery, how they arise, the interaction of both types of antibodies with their molecular targets, and the attempts that have been made to reproduce human neuronal injury in tissue culture models and experimental animals.
  • We then discuss the emerging area of autoimmune neuronal injury associated with immune checkpoint inhibitors and the implications of current research for the treatment of affected patients.

 

COVID-19 Antigen Rapid Test Pen (Saliva)

Panbio 2

The Rapid Response COVID-19 Antigen Rapid Test Pen (Saliva) is an in vitro immunoassay. The assay is for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from saliva samples through visual interpretation of colour development. This test is intended for professional use only.

Key Benefits:

• First and the only no-spit test dedicated to COVID-19 – Its sponge-like pen tip will collect a sufficient volume of specimen in 2 mins without the need to spit and avoiding uncomfortable nasal/throat swabbing.
• ALL IN ONE – No need to waste time setting up a workstation and handle numerous assay components. All you need is one pen that can be used comfortably in any location.

Test Principle 

Anti-SARS-CoV-2 antibodies are immobilized on the test region of the nitrocellulose membrane. Anti-SARS-CoV-2 antibodies conjugated to coloured particles are immobilized on the conjugated pad. A sample is added to the extraction buffer which is optimized to release the SARS-CoV-2 antigens from specimen. During testing, target antigens, if present in the saliva samples, will be released into the extraction buffer individually packed in the kit. Consequently, the extracted antigens will bind to anti-SARS-CoV-2 antibodies conjugated to coloured particles

As the specimen migrates along the strip by capillary action and interacts with reagents on the membrane, the complex will be captured by the anti-SARS-CoV-2 antibodies at the test region. Excess coloured particles are captured at the internal control zone. The presence of a coloured band in the test region indicates a positive result for the SARS-CoV-2 viral antigens, while its absence indicates a negative result. A coloured band at the control region serves as a procedural control, indicating that the proper volume of specimen has been added and membrane wicking is working.

 

ï¿­ INVBIO saliva alcohol screening test kit detects alcohol presence in saliva. Therefore, directly dipping the strip into alcohol alone will not provide you with an accurate reading.
ï¿­ It is very important that the test be read at exactly two minutes, The result you read 2 minutes after saturation with saliva is the accurate test result.
ï¿­Nothing should be placed into the mouth of the subject for at least 10 minutes prior to saliva collection. This includes food, drink, tobacco products or other materials.

SPECIMEN COLLECTION AND PREPARATION
ï¿­Nothing should be placed into the mouth of the subject for at least 10 minutes prior to saliva collection. This includes food, drink, tobacco products or other materials.
ï¿­ Saliva specimen can be collected in a sputum cup or a clean container, or directly applied to the reaction pad of the test strip.

PROCEDURE:
Open the foil package and remove the test strip.
Saturate the reactive pad by dipping the reaction pad into the saliva specimen collected in a cup, or saturate the reactive pad on the end of stick with saliva in mouth for 10 seconds, shake off the excess saliva.
Immediately start timer and at exactly 2 minutes, compare the reactive pad with the provided colored chart.
Results after more than 2 minutes may be not accurate.

INTERPRETATION OF RESULTS:
­ Negative: Almost no color change by comparing with the background. The negative result indicates that the BAC is less than 0.02%.
­ Positive: A distinct color developed all over the pad. The positive result indicates that the BAC is 0.02% or higher.
­ Invalid: The test should be considered invalid If only the edge of the reactive pad turned color that might be ascribed to insufficient sampling.

 

Luminex MAGPIX NATtrol

This examination was carried out to examine the results of indole-3-acetate sodium (IAA-Na) inclusion in diets on the egg manufacturing efficiency, egg high quality, intestinal tissue morphology, serum hormone ranges and biochemical parameters of Danzhou chickens to preliminarily discover the efficacy of IAA-Na as a feed additive. A complete of 192 Danzhou chickens (50 weeks previous) have been randomly assigned to 2 teams of 96. The diets for the therapy group consisted of basal diets, supplemented with IAA-Na (200 mg/kg).
The formal feeding trial lasted for 4 weeks. The outcomes confirmed that the feed supplemented with IAA-Na not solely elevated the laying charge (p < 0.05) and egg yolk ratio (0.05 < p < 0.1), but additionally considerably lowered the feed:egg ratio (p < 0.05). In addition, the dietary supplementation of IAA-Na considerably elevated the serum estradiol ranges (p < 0.05) and decreased serum alkaline phosphatase exercise (p < 0.05).
Compared with the management group, the addition of IAA-Na to the weight-reduction plan had no important impact on the intestinal tissue morphology or serum antioxidant capability of Danzhou chickens. This examination preliminarily gives proof that dietary IAA-Na can enhance laying efficiency, indicating that IAA-Na is a doubtlessly efficient feed additive for laying hens, however additional research are required earlier than arriving at particular conclusions.

Luminex MAGPIX NATtrol aimed zinc (Zn) supplementation and serum ranges of copeptin, high-sensitive C-reactive protein (hs-CRP), glycemic management, anthropometric parameters and renal operate in Zn -deficient diabetic hemodialysis patients (DHPs). This randomized, double-blind, placebo-controlled trial (RCT) was carried out on 46 DHPs with Zn-deficiency.

The Zn complement group (n = 21) acquired a 220-mg/day Zn sulfate capsule (containing 50 mg Zn), and the management group (n = 25) acquired a placebo capsule (220 mg corn starch), for eight weeks. Fasting, predialysis blood samples have been taken at baseline and after eight weeks to assess fasting blood glucose (FBG), serum insulin, copeptin, high-sensitive C-reactive protein (hs-CRP), blood urea nitrogen (BUN), creatinine (Cr) concentrations, and homoeostatic mannequin evaluation (HOMA-IR) and quantitative insulin-sensitivity verify index (QUICKI).
Compared to controls, serum copeptin (P < 0.001), hs-CRP (P < 0.001), BUN (P < 0.001), Cr (P < 0.001), Zn (P < 0.001), FBG (P < 0.001) ranges, BMI (P < 0.001), and physique weight (P < 0.001) have been considerably affected following ZnSO4 supplementation for eight weeks. In distinction, QUICKI (P = 0.57), HOMA-IR (P = 0.60), and serum insulin (P = 0.55) weren’t affected following Zn supplementation in comparability with patients receiving placebo. Zn sulfate supplementation seems to have favorable results on serum copeptin and hs-CRP, FBG, and renal operate in Zn-deficient DHPs. Iranian Registry of Clinical Trials Identifier: IRCT20190806044461N1.

Histopathological examination of newly-developed adhesive silicone denture relining material.

Histopathological examination of newly-developed adhesive silicone denture relining material.

We aimed to guage the subcutaneous tissue response to a newly developed adhesive silicone denture relining materials, SG, (Neo Dental Chemical Products Co., Ltd. Tokyo, Japan). We embedded the experimental materials SG and one other present management materials, Roeko Seal (RS), within the dorsal space of 22 male ddY mice.

One week and 12 weeks after the embedding, the tissues surrounding the embedded supplies had been eliminated and a histopathological examination was carried out. The outcomes reveal that the essential histopathological elements are the formation of granulation tissue and the change of the tissue to fibrous capsule over time.

The outcomes means that the newly-developed SG is secure as in contrast with the management RS, whose composition is comparable.

Histopathological examination of newly-developed adhesive silicone denture relining material.
Histopathological examination of newly-developed adhesive silicone denture relining materials.

Collaborative research on fifteen compounds within the rat-liver Comet assay built-in into 2- and 4-week repeat-dose research.

A collaborative trial was carried out to guage the likelihood of integrating the rat-liver Comet assay into repeat-dose toxicity research. Fourteen laboratories from Europe, Japan and the USA examined fifteen chemical compounds.

Two chemical compounds had been beforehand proven to induce micronuclei in an acute protocol, however had been discovered unfavorable in a 4-week Micronucleus (MN) Assay (benzo[a]pyrene and 1,2-dimethylhydrazine; Hamada et al., 2001); 4 genotoxic rat-liver carcinogens that had been unfavorable within the MN assay in bone marrow or blood (2,6-dinitrotoluene, dimethylnitrosamine, 1,2-dibromomethane, and 2-amino-3-methylimidazo[4,5-f]quinoline); three compounds used within the ongoing JaCVAM (Japanese Center for the Validation of Alternative Methods) validation research of the acute liver Comet assay (2,4-diaminotoluene, 2,6-diaminotoluene and acrylamide); three pharmaceutical-like compounds (chlordiazepoxide, pyrimethamine and gemifloxacin), and three non-genotoxic rodent liver carcinogens (methapyrilene, clofibrate and phenobarbital). Male rats obtained oral administrations of the take a look at compounds, each day for 2 or 4 weeks.

EDEM2 Antibody

6633-100 each
EUR 418.8

EDEM2 Antibody

6633-30T each
EUR 175.2

EDEM2 Antibody

46557-100ul 100ul
EUR 302.4

EDEM2 Antibody

ABD9503 100 ug
EUR 525.6

EDEM2 Antibody

1-CSB-PA030228
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000

EDEM2 Antibody

1-CSB-PA861146LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

EDEM2 Antibody

E306231 100ug/200ul
EUR 275
Description: Available in various conjugation types.

EDEM2 Antibody

DF9503 100ul
EUR 280
Description: Human,Mouse,Monkey

EDEM2 Antibody

DF9503-100ul 100ul
EUR 280

EDEM2 Antibody

DF9503-200ul 200ul
EUR 350

EDEM2 Antibody

E046557 100μg/100μl
EUR 255
Description: Available in various conjugation types.

EDEM2 Antibody

E19-9503-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EDEM2 Antibody

E19-9503-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

anti- EDEM2 antibody

FNab02632 100µg
EUR 606.3
Description: Antibody raised against EDEM2

EDEM2 cloning plasmid

CSB-CL861146HU-10ug 10ug
EUR 451.2
Description: A cloning plasmid for the EDEM2 gene.

EDEM2 Blocking Peptide

6633BP-50 each
EUR 183.6

EDEM2 Blocking Peptide

DF9503-BP 1mg
EUR 234

Polyclonal EDEM2 Antibody

AMM07003G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EDEM2 . This antibody is tested and proven to work in the following applications:

EDEM2 Conjugated Antibody

C46557 100ul
EUR 476.4

EDEM2 Polyclonal Antibody

ABP55756-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of EDEM2 from Human. This EDEM2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human EDEM2

EDEM2 Polyclonal Antibody

ABP55756-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of EDEM2 from Human. This EDEM2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human EDEM2

EDEM2 Polyclonal Antibody

ABP55756-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of EDEM2 from Human. This EDEM2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human EDEM2

EDEM2 Polyclonal Antibody

A58890
  • EUR 684.66
  • EUR 117.70
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

EDEM2 Polyclonal Antibody

ES6755-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against EDEM2 from Human. This antibody is tested and validated for IHC, WB, ELISA

EDEM2 Polyclonal Antibody

ES6755-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against EDEM2 from Human. This antibody is tested and validated for IHC, WB, ELISA

EDEM2 Polyclonal Antibody

E917181 100ul
EUR 225
Description: Available in various conjugation types.

EDEM2 Polyclonal Antibody

E20-71458 100ug
EUR 225
Description: Available in various conjugation types.

EDEM2 ELISA KIT|Human

EF009290 96 Tests
EUR 826.8

Human EDEM2 ELISA KIT

ELI-32317h 96 Tests
EUR 988.8

Human EDEM2 shRNA Plasmid

20-abx960878
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

EDEM2 Antibody, HRP conjugated

1-CSB-PA861146LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

EDEM2 Recombinant Protein (Rat)

RP199049 100 ug Ask for price

EDEM2 Antibody, FITC conjugated

1-CSB-PA861146LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

EDEM2 Recombinant Protein (Human)

RP010159 100 ug Ask for price

EDEM2 Recombinant Protein (Mouse)

RP130856 100 ug Ask for price

EDEM2 Antibody, Biotin conjugated

1-CSB-PA861146LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Edem2 ORF Vector (Rat) (pORF)

ORF066351 1.0 ug DNA
EUR 607.2

EDEM2 ORF Vector (Human) (pORF)

ORF003387 1.0 ug DNA
EUR 114

Edem2 ORF Vector (Mouse) (pORF)

ORF043620 1.0 ug DNA
EUR 607.2

Human EDEM2 Protein, His Tag

E40KMPH5204 20ug
EUR 495

Human EDEM2 Protein Lysate 20ug

IHUEDEM2PLLY20UG each
EUR 213
Description: Human EDEM2 Protein Lysate 20ug

EDEM2 Polyclonal Antibody, HRP Conjugated

A58893
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

EDEM2 Polyclonal Antibody, FITC Conjugated

A58892
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

EDEM2 Polyclonal Antibody, Biotin Conjugated

A58891
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Edem2 sgRNA CRISPR Lentivector set (Rat)

K7428201 3 x 1.0 ug
EUR 406.8

Edem2 3'UTR GFP Stable Cell Line

TU253777 1.0 ml Ask for price

Edem2 3'UTR GFP Stable Cell Line

TU155598 1.0 ml Ask for price

EDEM2 3'UTR GFP Stable Cell Line

TU056560 1.0 ml
EUR 1672.8

EDEM2 sgRNA CRISPR Lentivector set (Human)

K0653501 3 x 1.0 ug
EUR 406.8

Edem2 sgRNA CRISPR Lentivector set (Mouse)

K3235601 3 x 1.0 ug
EUR 406.8

EDEM2 Protein Vector (Rat) (pPM-C-HA)

PV265404 500 ng
EUR 723.6

EDEM2 Protein Vector (Rat) (pPB-C-His)

PV265402 500 ng
EUR 723.6

EDEM2 Protein Vector (Rat) (pPB-N-His)

PV265403 500 ng
EUR 723.6

EDEM2 Protein Vector (Rat) (pPM-C-His)

PV265405 500 ng
EUR 723.6

EDEM2 Protein Vector (Human) (pPM-C-HA)

PV013547 500 ng
EUR 394.8

EDEM2 Protein Vector (Mouse) (pPM-C-HA)

PV174480 500 ng
EUR 723.6

EDEM2 Protein Vector (Human) (pPB-C-His)

PV013545 500 ng
EUR 394.8

EDEM2 Protein Vector (Human) (pPB-N-His)

PV013546 500 ng
EUR 394.8

EDEM2 Protein Vector (Human) (pPM-C-His)

PV013548 500 ng
EUR 394.8

EDEM2 Protein Vector (Mouse) (pPB-C-His)

PV174478 500 ng
EUR 723.6

EDEM2 Protein Vector (Mouse) (pPB-N-His)

PV174479 500 ng
EUR 723.6

EDEM2 Protein Vector (Mouse) (pPM-C-His)

PV174481 500 ng
EUR 723.6

EDEM2 3'UTR Luciferase Stable Cell Line

TU006560 1.0 ml
EUR 1672.8

Edem2 3'UTR Luciferase Stable Cell Line

TU105598 1.0 ml Ask for price

Edem2 3'UTR Luciferase Stable Cell Line

TU203777 1.0 ml Ask for price

Edem2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K7428202 1.0 ug DNA
EUR 184.8

Edem2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K7428203 1.0 ug DNA
EUR 184.8

Edem2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K7428204 1.0 ug DNA
EUR 184.8

Monoclonal EDEM2 Antibody (clone 2E4), Clone: 2E4

AMM07004G 0.05mg
EUR 633.6
Description: A Monoclonal antibody against Human EDEM2 (clone 2E4). The antibodies are raised in Mouse and are from clone 2E4. This antibody is applicable in WB and IHC-P, E

EDEM2 sgRNA CRISPR Lentivector (Human) (Target 1)

K0653502 1.0 ug DNA
EUR 184.8

EDEM2 sgRNA CRISPR Lentivector (Human) (Target 2)

K0653503 1.0 ug DNA
EUR 184.8

EDEM2 sgRNA CRISPR Lentivector (Human) (Target 3)

K0653504 1.0 ug DNA
EUR 184.8

Edem2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3235602 1.0 ug DNA
EUR 184.8

Edem2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3235603 1.0 ug DNA
EUR 184.8

Edem2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3235604 1.0 ug DNA
EUR 184.8

EDEM2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV650983 1.0 ug DNA
EUR 818.4

EDEM2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV650987 1.0 ug DNA
EUR 818.4

EDEM2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV650988 1.0 ug DNA
EUR 818.4

EDEM2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV791509 1.0 ug DNA
EUR 379.2

EDEM2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV791510 1.0 ug DNA
EUR 379.2

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7428205 3 x 1.0 ug
EUR 451.2

EDEM2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0653505 3 x 1.0 ug
EUR 451.2

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3235605 3 x 1.0 ug
EUR 451.2

ER Degradation Enhancer, Mannosidase Alpha-Like 2 (EDEM2) Antibody

abx232632-100ug 100 ug
EUR 577.2

ER Degradation Enhancer, Mannosidase Alpha-Like 2 (EDEM2) Antibody

abx036086-100ug 100 ug
EUR 469.2

ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) Antibody

20-abx322885
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

ER Degradation Enhancer, Mannosidase Alpha-Like 2 (EDEM2) Antibody

20-abx310614
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7428206 1.0 ug DNA
EUR 200.4

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7428207 1.0 ug DNA
EUR 200.4

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7428208 1.0 ug DNA
EUR 200.4

ER Degradation Enhancer, Mannosidase Alpha-Like 2 (EDEM2) Antibody (HRP)

20-abx310615
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

EDEM2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0653506 1.0 ug DNA
EUR 200.4

EDEM2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0653507 1.0 ug DNA
EUR 200.4

EDEM2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0653508 1.0 ug DNA
EUR 200.4

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3235606 1.0 ug DNA
EUR 200.4

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3235607 1.0 ug DNA
EUR 200.4

Edem2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3235608 1.0 ug DNA
EUR 200.4

EDEM2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV650984 1.0 ug DNA
EUR 818.4

ER Degradation Enhancer, Mannosidase Alpha-Like 2 (EDEM2) Antibody (FITC)

20-abx310616
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

EDEM2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV650985 1.0 ug DNA
EUR 888

EDEM2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV650986 1.0 ug DNA
EUR 888

ER Degradation Enhancer, Mannosidase Alpha-Like 2 (EDEM2) Antibody (Biotin)

20-abx310617
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

EDEM2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV791507 1.0 ug DNA
EUR 448.8

EDEM2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV791508 1.0 ug DNA
EUR 448.8

Human ER Degradation Enhancer, Mannosidase alpha-Like 2 (EDEM2) ELISA Kit

abx387046-96tests 96 tests
EUR 1093.2

EDEM1 siRNA

20-abx914949
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM1 siRNA

20-abx914950
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM3 siRNA

20-abx914952
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM3 siRNA

20-abx914953
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM1 Antibody

3904-100 each
EUR 444

EDEM1 Antibody

3904-30T each
EUR 175.2

EDEM1 antibody

70R-6871 50 ug
EUR 560.4
Description: Rabbit polyclonal EDEM1 antibody raised against the N terminal of EDEM1

EDEM1 Antibody

47091-100ul 100ul
EUR 302.4

EDEM1 Antibody

45971-100ul 100ul
EUR 302.4

EDEM1 Antibody

45971-50ul 50ul
EUR 224.4

EDEM3 Antibody

45972-100ul 100ul
EUR 302.4

EDEM3 Antibody

45972-50ul 50ul
EUR 224.4

EDEM1 Antibody

ABD9502 100 ug
EUR 525.6

EDEM3 Antibody

ABD9504 100 ug
EUR 525.6

EDEM1 Antibody

1-CSB-PA838793LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EDEM1. Recognizes EDEM1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:200-1:500

EDEM3 Antibody

RQ6618 100ug
EUR 356.15
Description: ER degradation-enhancing alpha-mannosidase-like 3 is an enzyme that in humans is encoded by the EDEM3 gene. Quality control in the endoplasmic reticulum (ER) ensures that only properly folded proteins are retained in the cell through recognition and degradation of misfolded or unassembled proteins. EDEM3 belongs to a group of proteins that accelerate degradation of misfolded glycoproteins in the ER.

EDEM1 Antibody

E38PA3584 100ul
EUR 225
Description: Available in various conjugation types.

EDEM1 Antibody

DF9502 100ul
EUR 280
Description: Human,Mouse

EDEM3 Antibody

DF9504 100ul
EUR 280
Description: Human,Mouse

EDEM1 Antibody

DF9502-100ul 100ul
EUR 280

EDEM1 Antibody

DF9502-200ul 200ul
EUR 350

EDEM3 Antibody

DF9504-100ul 100ul
EUR 280

EDEM3 Antibody

DF9504-200ul 200ul
EUR 350

EDEM1 Antibody

E047091 100μg/100μl
EUR 255
Description: Available in various conjugation types.

EDEM1 Antibody

E19-9502-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EDEM1 Antibody

E19-9502-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

EDEM3 Antibody

E19-9504-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EDEM3 Antibody

E19-9504-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Human EDEM1 ELISA KIT

ELI-47111h 96 Tests
EUR 988.8

Human EDEM3 ELISA KIT

ELI-47172h 96 Tests
EUR 988.8

Mouse Edem1 ELISA KIT

ELI-26124m 96 Tests
EUR 1038

Mouse Edem3 ELISA KIT

ELI-26645m 96 Tests
EUR 1038

Edem3 ORF Vector (Rat) (pORF)

ORF066352 1.0 ug DNA
EUR 607.2

EDEM3 cloning plasmid

CSB-CL863170HU-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the EDEM3 gene.

EDEM3 ORF Vector (Human) (pORF)

ORF003388 1.0 ug DNA
EUR 114

Edem1 ORF Vector (Mouse) (pORF)

ORF043619 1.0 ug DNA
EUR 607.2

Edem3 ORF Vector (Mouse) (pORF)

ORF043621 1.0 ug DNA
EUR 607.2

EDEM1 ORF Vector (Human) (pORF)

ORF018683 1.0 ug DNA
EUR 486

Edem1 3'UTR GFP Stable Cell Line

TU253776 1.0 ml Ask for price

Edem3 3'UTR GFP Stable Cell Line

TU253778 1.0 ml Ask for price

Edem1 3'UTR GFP Stable Cell Line

TU155597 1.0 ml Ask for price

Edem3 3'UTR GFP Stable Cell Line

TU155599 1.0 ml Ask for price

EDEM1 3'UTR GFP Stable Cell Line

TU056559 1.0 ml
EUR 2799.6

EDEM3 3'UTR GFP Stable Cell Line

TU056561 1.0 ml
EUR 2799.6

Human EDEM1 shRNA Plasmid

20-abx956466
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse EDEM3 shRNA Plasmid

20-abx975889
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse EDEM1 shRNA Plasmid

20-abx980418
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human EDEM3 shRNA Plasmid

20-abx962830
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

EDEM1 Blocking Peptide

3904BP-50 each
EUR 183.6

EDEM3 Blocking Peptide

3614BP-50 each
EUR 183.6

EDEM1 Blocking Peptide

33R-5674 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EDEM1 antibody, catalog no. 70R-6871

EDEM1 Blocking Peptide

DF9502-BP 1mg
EUR 234

EDEM3 Blocking Peptide

DF9504-BP 1mg
EUR 234

EDEM1 Blocking Peptide

20-abx161085
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

Polyclonal EDEM3 Antibody

AMM07005G 0.1mg
EUR 633.6
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EDEM3 . This antibody is tested and proven to work in the following applications:

EDEM1 Conjugated Antibody

C45971 100ul
EUR 476.4

EDEM3 Conjugated Antibody

C45972 100ul
EUR 476.4

EDEM1 Conjugated Antibody

C47091 100ul
EUR 476.4

EDEM1 Polyclonal Antibody

ABP58453-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of EDEM1 from Human, Mouse. This EDEM1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM1 protein

EDEM1 Polyclonal Antibody

ABP58453-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of EDEM1 from Human, Mouse. This EDEM1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM1 protein

EDEM1 Polyclonal Antibody

ABP58453-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of EDEM1 from Human, Mouse. This EDEM1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM1 protein

EDEM3 Polyclonal Antibody

ABP58454-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of EDEM3 from Human, Mouse. This EDEM3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM3 protein

EDEM3 Polyclonal Antibody

ABP58454-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of EDEM3 from Human, Mouse. This EDEM3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM3 protein

EDEM3 Polyclonal Antibody

ABP58454-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of EDEM3 from Human, Mouse. This EDEM3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM3 protein

The prime dose was meant to be the very best dose producing scientific indicators or histopathological results with out inflicting mortality, i.e. the 28-day most tolerated dose. The liver Comet assay was carried out in accordance with revealed suggestions and following the protocol for the continuing JaCVAM validation trial. Laboratories supplied liver Comet assay knowledge obtained on the finish of the long-term (2- or 4-week) research along with an analysis of liver histology.

Most of the take a look at compounds had been additionally investigated within the liver Comet assay after short-term (1-Three each day) administration to match the sensitivity of the 2 research designs. MN analyses had been carried out in bone marrow or peripheral blood for many of the compounds to find out whether or not the liver Comet assay might complement the MN assay for the detection of genotoxins after long-term therapy.

Most of the liver genotoxins had been optimistic and the three non-genotoxic carcinogens gave unfavorable end result within the liver Comet assay after long-term administration. There was a excessive concordance between short- and long-term Comet assay outcomes. Most compounds when examined as much as the utmost tolerated dose had been accurately detected in each short- and long-term research.

Discrepant outcomes had been obtained with 2,6 diaminotoluene (unfavorable within the short-term, however optimistic within the long-term research), phenobarbital (optimistic within the short-term, however unfavorable within the long-term research) and gemifloxacin (optimistic within the short-term, however unfavorable within the long-term research).

The total outcomes point out that the liver Comet assay will be built-in inside repeat-dose toxicity research and effectively enhances the MN assay in detecting genotoxins. Practical elements of integrating genotoxicity endpoints into repeat-dose research had been evaluated, e.g. by investigating the impact of blood sampling, as usually carried out throughout toxicity research, on the Comet and MN assays.

The bleeding protocols used right here didn’t have an effect on the conclusions of the Comet assay or of the MN assays in blood and bone marrow. Although bleeding typically elevated reticulocyte frequencies, the sensitivity of the response within the MN assay was not altered. 

FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas.

FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas.

Edible brown algae are used as main meals materials in Far East Asian international locations, significantly in South Korea and Japan. They comprise fermentable dietary fibers, alginic acid (uronic acid polymer) and laminaran (β-1,3-glucan), which can be fermented into natural acids by intestinal micro organism.

To make clear the impact of edible algae on the intestinal setting, the cecal microbiotas of rats fed diets containing no dietary fiber (management) or 2% (wt/wt) sodium alginate or laminaran for two weeks have been analyzed utilizing FLX amplicon pyrosequencing with bar-coded primers focusing on the bacterial 16S rRNA gene. The most considerable phylum in all teams was Firmicutes.

Specifically, Allobaculum was dominant in all food regimen teams. In addition, Bacteroides capillosus (37.1%) was considerable in the alginate group, whereas Clostridium ramosum (3.14%) and Parabacteroides distasonis (1.36%) have been solely detected in the laminaran group. Furthermore, rats fed alginate confirmed simplified microbiota phylotypes in contrast with others. With respect to cecal chemical compounds, laminaran increased cecal natural acid ranges, significantly propionic acid. Alginate elevated complete cecal natural acids.

Cecal putrefactive compounds, comparable to indole, H(2)S, and phenol, have been decreased by each alginate and laminaran. These outcomes point out that edible brown algae can alter the intestinal setting, with fermentation by intestinal microbiota.

FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas.
FLX pyrosequencing analysis of the effects of the brown-algal fermentable polysaccharides alginate and laminaran on rat cecal microbiotas.

Tsunami lung.

We encountered three instances of lung issues attributable to drowning in the current massive tsunami that struck following the Great East Japan Earthquake. All three have been females, and two of them have been outdated aged. All segments of each lungs have been concerned in all the three sufferers, necessitating ICU admission and endotracheal intubation and mechanical air flow. All three died inside 3 weeks.

EDEM3 Antibody

45972-100ul 100ul
EUR 302.4

EDEM3 Antibody

45972-50ul 50ul
EUR 224.4

EDEM3 Antibody

ABD9504 100 ug
EUR 525.6

EDEM3 Antibody

RQ6618 100ug
EUR 356.15
Description: ER degradation-enhancing alpha-mannosidase-like 3 is an enzyme that in humans is encoded by the EDEM3 gene. Quality control in the endoplasmic reticulum (ER) ensures that only properly folded proteins are retained in the cell through recognition and degradation of misfolded or unassembled proteins. EDEM3 belongs to a group of proteins that accelerate degradation of misfolded glycoproteins in the ER.

EDEM3 Antibody

DF9504 100ul
EUR 280
Description: Human,Mouse

EDEM3 Antibody

DF9504-100ul 100ul
EUR 280

EDEM3 Antibody

DF9504-200ul 200ul
EUR 350

EDEM3 Antibody

E19-9504-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EDEM3 Antibody

E19-9504-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

EDEM3 cloning plasmid

CSB-CL863170HU-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the EDEM3 gene.

EDEM3 Blocking Peptide

3614BP-50 each
EUR 183.6

EDEM3 Blocking Peptide

DF9504-BP 1mg
EUR 234

Polyclonal EDEM3 Antibody

AMM07005G 0.1mg
EUR 633.6
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EDEM3 . This antibody is tested and proven to work in the following applications:

EDEM3 Conjugated Antibody

C45972 100ul
EUR 476.4

EDEM3 Polyclonal Antibody

ABP58454-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of EDEM3 from Human, Mouse. This EDEM3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM3 protein

EDEM3 Polyclonal Antibody

ABP58454-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of EDEM3 from Human, Mouse. This EDEM3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM3 protein

EDEM3 Polyclonal Antibody

ABP58454-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of EDEM3 from Human, Mouse. This EDEM3 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM3 protein

EDEM3 Polyclonal Antibody

ES9649-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against EDEM3 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

EDEM3 Polyclonal Antibody

ES9649-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against EDEM3 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

EDEM3 Polyclonal Antibody

E11-200703 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Human EDEM3 ELISA KIT

ELI-47172h 96 Tests
EUR 988.8

Mouse Edem3 ELISA KIT

ELI-26645m 96 Tests
EUR 1038

Mouse EDEM3 shRNA Plasmid

20-abx975889
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human EDEM3 shRNA Plasmid

20-abx962830
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Edem3 ORF Vector (Rat) (pORF)

ORF066352 1.0 ug DNA
EUR 607.2

EDEM3 ORF Vector (Human) (pORF)

ORF003388 1.0 ug DNA
EUR 114

Edem3 ORF Vector (Mouse) (pORF)

ORF043621 1.0 ug DNA
EUR 607.2

Human EDEM3 Protein Lysate 20ug

IHUEDEM3PLLY20UG each
EUR 361
Description: Human EDEM3 Protein Lysate 20ug

Edem3 sgRNA CRISPR Lentivector set (Rat)

K6190401 3 x 1.0 ug
EUR 406.8

Edem3 3'UTR GFP Stable Cell Line

TU253778 1.0 ml Ask for price

Edem3 3'UTR GFP Stable Cell Line

TU155599 1.0 ml Ask for price

EDEM3 3'UTR GFP Stable Cell Line

TU056561 1.0 ml
EUR 2799.6

EDEM3 sgRNA CRISPR Lentivector set (Human)

K0653601 3 x 1.0 ug
EUR 406.8

Edem3 sgRNA CRISPR Lentivector set (Mouse)

K3468201 3 x 1.0 ug
EUR 406.8

EDEM3 Protein Vector (Rat) (pPM-C-HA)

PV265408 500 ng
EUR 1399.2

EDEM3 Protein Vector (Rat) (pPB-C-His)

PV265406 500 ng
EUR 1399.2

EDEM3 Protein Vector (Rat) (pPB-N-His)

PV265407 500 ng
EUR 1399.2

EDEM3 Protein Vector (Rat) (pPM-C-His)

PV265409 500 ng
EUR 1399.2

EDEM3 Protein Vector (Human) (pPM-C-HA)

PV013551 500 ng
EUR 394.8

EDEM3 Protein Vector (Mouse) (pPM-C-HA)

PV174484 500 ng
EUR 1278

EDEM3 Protein Vector (Human) (pPB-C-His)

PV013549 500 ng
EUR 394.8

EDEM3 Protein Vector (Human) (pPB-N-His)

PV013550 500 ng
EUR 394.8

EDEM3 Protein Vector (Human) (pPM-C-His)

PV013552 500 ng
EUR 394.8

EDEM3 Protein Vector (Mouse) (pPB-C-His)

PV174482 500 ng
EUR 1278

EDEM3 Protein Vector (Mouse) (pPB-N-His)

PV174483 500 ng
EUR 1278

EDEM3 Protein Vector (Mouse) (pPM-C-His)

PV174485 500 ng
EUR 1278

EDEM3 3'UTR Luciferase Stable Cell Line

TU006561 1.0 ml
EUR 2799.6

Edem3 3'UTR Luciferase Stable Cell Line

TU105599 1.0 ml Ask for price

Edem3 3'UTR Luciferase Stable Cell Line

TU203778 1.0 ml Ask for price

Edem3 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6190402 1.0 ug DNA
EUR 184.8

Edem3 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6190403 1.0 ug DNA
EUR 184.8

Edem3 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6190404 1.0 ug DNA
EUR 184.8

EDEM3 sgRNA CRISPR Lentivector (Human) (Target 1)

K0653602 1.0 ug DNA
EUR 184.8

EDEM3 sgRNA CRISPR Lentivector (Human) (Target 2)

K0653603 1.0 ug DNA
EUR 184.8

EDEM3 sgRNA CRISPR Lentivector (Human) (Target 3)

K0653604 1.0 ug DNA
EUR 184.8

Edem3 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3468202 1.0 ug DNA
EUR 184.8

Edem3 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3468203 1.0 ug DNA
EUR 184.8

Edem3 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3468204 1.0 ug DNA
EUR 184.8

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6190405 3 x 1.0 ug
EUR 451.2

EDEM3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0653605 3 x 1.0 ug
EUR 451.2

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3468205 3 x 1.0 ug
EUR 451.2

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6190406 1.0 ug DNA
EUR 200.4

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6190407 1.0 ug DNA
EUR 200.4

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6190408 1.0 ug DNA
EUR 200.4

EDEM3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0653606 1.0 ug DNA
EUR 200.4

EDEM3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0653607 1.0 ug DNA
EUR 200.4

EDEM3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0653608 1.0 ug DNA
EUR 200.4

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3468206 1.0 ug DNA
EUR 200.4

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3468207 1.0 ug DNA
EUR 200.4

Edem3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3468208 1.0 ug DNA
EUR 200.4

ER Degradation-Enhancing Alpha-Mannosidase-Like Protein 3 (EDEM3) Antibody

20-abx215068
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

ER Degradation-Enhancing Alpha-Mannosidase-Like Protein 3 (EDEM3) Antibody

abx028901-400ul 400 ul
EUR 627.6

ER Degradation-Enhancing Alpha-Mannosidase-Like Protein 3 (EDEM3) Antibody

abx028901-80l 80 µl
EUR 343.2

EDEM1 siRNA

20-abx914949
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM1 siRNA

20-abx914950
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM2 siRNA

20-abx914951
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EDEM1 Antibody

3904-100 each
EUR 444

EDEM1 Antibody

3904-30T each
EUR 175.2

EDEM2 Antibody

40055-100ul 100ul
EUR 468

EDEM2 Antibody

6633-100 each
EUR 418.8

EDEM2 Antibody

6633-30T each
EUR 175.2

EDEM1 antibody

70R-6871 50 ug
EUR 560.4
Description: Rabbit polyclonal EDEM1 antibody raised against the N terminal of EDEM1

EDEM2 Antibody

46557-100ul 100ul
EUR 302.4

EDEM1 Antibody

47091-100ul 100ul
EUR 302.4

EDEM1 Antibody

45971-100ul 100ul
EUR 302.4

EDEM1 Antibody

45971-50ul 50ul
EUR 224.4

EDEM1 Antibody

ABD9502 100 ug
EUR 525.6

EDEM2 Antibody

ABD9503 100 ug
EUR 525.6

EDEM2 Antibody

1-CSB-PA030228
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000

EDEM1 Antibody

1-CSB-PA838793LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EDEM1. Recognizes EDEM1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:200-1:500

EDEM2 Antibody

1-CSB-PA861146LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

EDEM1 Antibody

E38PA3584 100ul
EUR 225
Description: Available in various conjugation types.

EDEM2 Antibody

E306231 100ug/200ul
EUR 275
Description: Available in various conjugation types.

EDEM1 Antibody

DF9502 100ul
EUR 280
Description: Human,Mouse

EDEM2 Antibody

DF9503 100ul
EUR 280
Description: Human,Mouse,Monkey

EDEM1 Antibody

DF9502-100ul 100ul
EUR 280

EDEM1 Antibody

DF9502-200ul 200ul
EUR 350

EDEM2 Antibody

DF9503-100ul 100ul
EUR 280

EDEM2 Antibody

DF9503-200ul 200ul
EUR 350

EDEM2 Antibody

E046557 100μg/100μl
EUR 255
Description: Available in various conjugation types.

EDEM1 Antibody

E047091 100μg/100μl
EUR 255
Description: Available in various conjugation types.

EDEM1 Antibody

E19-9502-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EDEM1 Antibody

E19-9502-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

EDEM2 Antibody

E19-9503-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EDEM2 Antibody

E19-9503-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Human EDEM1 ELISA KIT

ELI-47111h 96 Tests
EUR 988.8

EDEM2 ELISA KIT|Human

EF009290 96 Tests
EUR 826.8

Mouse Edem1 ELISA KIT

ELI-26124m 96 Tests
EUR 1038

Human EDEM2 ELISA KIT

ELI-32317h 96 Tests
EUR 988.8

Edem2 ORF Vector (Rat) (pORF)

ORF066351 1.0 ug DNA
EUR 607.2

anti- EDEM2 antibody

FNab02632 100µg
EUR 606.3
Description: Antibody raised against EDEM2

EDEM2 cloning plasmid

CSB-CL861146HU-10ug 10ug
EUR 451.2
Description: A cloning plasmid for the EDEM2 gene.

EDEM2 ORF Vector (Human) (pORF)

ORF003387 1.0 ug DNA
EUR 114

Edem1 ORF Vector (Mouse) (pORF)

ORF043619 1.0 ug DNA
EUR 607.2

Edem2 ORF Vector (Mouse) (pORF)

ORF043620 1.0 ug DNA
EUR 607.2

EDEM1 ORF Vector (Human) (pORF)

ORF018683 1.0 ug DNA
EUR 486

Edem1 3'UTR GFP Stable Cell Line

TU253776 1.0 ml Ask for price

Edem2 3'UTR GFP Stable Cell Line

TU253777 1.0 ml Ask for price

Human EDEM2 Protein, His Tag

E40KMPH5204 20ug
EUR 495

Edem1 3'UTR GFP Stable Cell Line

TU155597 1.0 ml Ask for price

Edem2 3'UTR GFP Stable Cell Line

TU155598 1.0 ml Ask for price

EDEM1 3'UTR GFP Stable Cell Line

TU056559 1.0 ml
EUR 2799.6

EDEM2 3'UTR GFP Stable Cell Line

TU056560 1.0 ml
EUR 1672.8

Human EDEM1 shRNA Plasmid

20-abx956466
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse EDEM1 shRNA Plasmid

20-abx980418
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human EDEM2 shRNA Plasmid

20-abx960878
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

EDEM1 Blocking Peptide

3904BP-50 each
EUR 183.6

EDEM2 Blocking Peptide

6633BP-50 each
EUR 183.6

EDEM1 Blocking Peptide

33R-5674 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EDEM1 antibody, catalog no. 70R-6871

EDEM1 Blocking Peptide

DF9502-BP 1mg
EUR 234

EDEM2 Blocking Peptide

DF9503-BP 1mg
EUR 234

EDEM1 Blocking Peptide

20-abx161085
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

Polyclonal EDEM2 Antibody

AMM07003G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EDEM2 . This antibody is tested and proven to work in the following applications:

EDEM1 Conjugated Antibody

C45971 100ul
EUR 476.4

EDEM2 Conjugated Antibody

C46557 100ul
EUR 476.4

EDEM1 Conjugated Antibody

C47091 100ul
EUR 476.4

EDEM1 Polyclonal Antibody

ABP58453-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of EDEM1 from Human, Mouse. This EDEM1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM1 protein

EDEM1 Polyclonal Antibody

ABP58453-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of EDEM1 from Human, Mouse. This EDEM1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM1 protein

EDEM1 Polyclonal Antibody

ABP58453-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of EDEM1 from Human, Mouse. This EDEM1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human EDEM1 protein

EDEM2 Polyclonal Antibody

ABP55756-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of EDEM2 from Human. This EDEM2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human EDEM2

EDEM2 Polyclonal Antibody

ABP55756-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of EDEM2 from Human. This EDEM2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human EDEM2

EDEM2 Polyclonal Antibody

ABP55756-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of EDEM2 from Human. This EDEM2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human EDEM2

EDEM2 Polyclonal Antibody

A58890
  • EUR 684.66
  • EUR 117.70
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

EDEM2 Polyclonal Antibody

ES6755-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against EDEM2 from Human. This antibody is tested and validated for IHC, WB, ELISA

EDEM2 Polyclonal Antibody

ES6755-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against EDEM2 from Human. This antibody is tested and validated for IHC, WB, ELISA

EDEM1 Polyclonal Antibody

ES9648-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against EDEM1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

EDEM1 Polyclonal Antibody

ES9648-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against EDEM1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

EDEM2 Protein Vector (Rat) (pPM-C-HA)

PV265404 500 ng
EUR 723.6

Human EDEM1 Protein Lysate 20ug

IHUEDEM1PLLY20UG each
EUR 213
Description: Human EDEM1 Protein Lysate 20ug

Human EDEM2 Protein Lysate 20ug

IHUEDEM2PLLY20UG each
EUR 213
Description: Human EDEM2 Protein Lysate 20ug

EDEM1 Polyclonal Antibody

E910579 100ul
EUR 225
Description: Available in various conjugation types.

EDEM2 Polyclonal Antibody

E917181 100ul
EUR 225
Description: Available in various conjugation types.

EDEM1 Polyclonal Antibody

E11-200702 100ug/100ul
EUR 225
Description: Available in various conjugation types.

EDEM2 Polyclonal Antibody

E20-71458 100ug
EUR 225
Description: Available in various conjugation types.

EDEM1 Antibody, HRP conjugated

1-CSB-PA838793LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EDEM1. Recognizes EDEM1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

EDEM2 Antibody, HRP conjugated

1-CSB-PA861146LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

EDEM2 Recombinant Protein (Rat)

RP199049 100 ug Ask for price

EDEM2 Protein Vector (Rat) (pPB-C-His)

PV265402 500 ng
EUR 723.6

EDEM2 Protein Vector (Rat) (pPB-N-His)

PV265403 500 ng
EUR 723.6

EDEM2 Protein Vector (Rat) (pPM-C-His)

PV265405 500 ng
EUR 723.6

EDEM1 Antibody, FITC conjugated

1-CSB-PA838793LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EDEM1. Recognizes EDEM1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

EDEM2 Antibody, FITC conjugated

1-CSB-PA861146LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EDEM2. Recognizes EDEM2 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

EDEM2 Protein Vector (Human) (pPM-C-HA)

PV013547 500 ng
EUR 394.8

EDEM1 Protein Vector (Mouse) (pPM-C-HA)

PV174476 500 ng
EUR 723.6

EDEM2 Protein Vector (Mouse) (pPM-C-HA)

PV174480 500 ng
EUR 723.6

EDEM1 Protein Vector (Human) (pPM-C-HA)

PV074731 500 ng
EUR 662.4

EDEM2 Protein Vector (Human) (pPB-C-His)

PV013545 500 ng
EUR 394.8

EDEM2 Protein Vector (Human) (pPB-N-His)

PV013546 500 ng
EUR 394.8

EDEM2 Protein Vector (Human) (pPM-C-His)

PV013548 500 ng
EUR 394.8

EDEM1 Protein Vector (Mouse) (pPB-C-His)

PV174474 500 ng
EUR 723.6

EDEM1 Protein Vector (Mouse) (pPB-N-His)

PV174475 500 ng
EUR 723.6

EDEM1 Protein Vector (Mouse) (pPM-C-His)

PV174477 500 ng
EUR 723.6

EDEM2 Protein Vector (Mouse) (pPB-C-His)

PV174478 500 ng
EUR 723.6

EDEM2 Protein Vector (Mouse) (pPB-N-His)

PV174479 500 ng
EUR 723.6

EDEM2 Protein Vector (Mouse) (pPM-C-His)

PV174481 500 ng
EUR 723.6

EDEM1 Protein Vector (Human) (pPB-C-His)

PV074729 500 ng
EUR 662.4

EDEM1 Protein Vector (Human) (pPB-N-His)

PV074730 500 ng
EUR 662.4

EDEM1 Protein Vector (Human) (pPM-C-His)

PV074732 500 ng
EUR 662.4

EDEM2 Recombinant Protein (Human)

RP010159 100 ug Ask for price

In no less than two instances, misswallowing of oil was suspected from the options famous at the time of the detection. Sputum tradition for micro organism yielded isolation of Stenotrophomonas maltophilia, Legionella pneumophila, Burkholderia cepacia, and Pseudomonas aeruginosa. The trigger of tsunami lung could also be a mix of chemical induced pneumonia and bacterial pneumonia.

Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity.

OBJECTIVE
To assess the medical efficacy of cultivated oral mucosal epithelial transplantation (COMET) for the remedy of persistent epithelial defect (PED).
METHODS
We handled 10 eyes of 9 sufferers with PED (Stevens-Johnson syndrome: three eyes; thermal/chemical harm: 5 eyes; ocular cicatricial pemphigoid: two eyes) with COMET at Kyoto Prefectural University of Medicine, Kyoto, Japan from 2002 to 2008.
RESULTS
Preoperatively, PED existed on over greater than 50% of the corneal surface in seven eyes. Severe ocular surface irritation with fibrovascular tissue surrounded the PED in all 10 eyes. At 24-weeks postoperative, PED had improved in all instances besides 1 in which the affected person was unable to return to the hospital (95% CI, 55.5-99.7; Wilcoxon signed-rank check, p = 0.0078).
The preoperative median of logarithmic minimal angle of decision was 1.85 (vary 0.15-2.70), and 1.85, 1.85, and 1.52 on the 4th, 12th, and 24th postoperative week, respectively.
The imply whole preoperative ocular surface grading rating was 7.0 (vary 4-17). At Four and 12 weeks postoperative, the whole ocular surface grading rating had improved considerably (p = 0.0020, p = 0.0078), and at 24 weeks postoperative, it was 3.0 (vary 2-12, p = 0.0234). During the follow-up interval (median 23.Three months, vary 5.6-39.7 months), no recurrence of PED was noticed in any eye, and long-term ocular surface stability was obtained.
CONCLUSIONS
COMET enabled full epithelialization of PED and stabilization of the ocular surface in sufferers with severe ocular surface illness, thus stopping end-stage cicatrization and imaginative and prescient loss at a later stage.
 Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity.
Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory exercise.

Antianxiety-like results of Chimpi (dried citrus peels) in the elevated open-platform check.

Dried citrus peels (Chimpi) is likely one of the most typical pure medicines with qi (power circulate) rectifying and shi (dampness) drying actions, which originates from Citrus unshiu, and/or C. reticulata in response to the definition of the pharmacopoeiae of Japan and China. In this examine, the pharmacological results of their extracts and main chemical constituents hesperidin and its aglycone hesperetin on nervousness had been examined with an nervousness mannequin of elevated open-platform check utilizing ICR male mice (6-week-old) and whole period of freezing was decreased in fluoxetine-treated mice, which is a straightforward and extremely delicate to the consequences of serotonergic anxiolytics.

EDTA, Disodium Salt, Dihydrate

CH034 2.5 kg
EUR 400.8

EDTA disodium salt dihydrate

GE3023-100G 100 g
EUR 48

EDTA disodium salt dihydrate

GE3023-1KG 1 kg
EUR 84

EDTA disodium salt dihydrate

GE3023-250G 250 g
EUR 55.2

EDTA disodium salt dihydrate

GE3023-500G 500 g
EUR 64.8

EDTA disodium salt dihydrate

GE3023-5KG 5 kg
EUR 180

EDTA, disodium salt, dihydrate

EB0185 500g
EUR 84.01

EDTA disodium salt dihydrate

GE3023-1 1
EUR 39.4

EDTA disodium salt dihydrate

GE3023-100 100
EUR 11.3

EDTA disodium salt dihydrate

GE3023-250 250
EUR 15.9

EDTA disodium salt dihydrate

GE3023-5 5
EUR 118.7

EDTA disodium salt dihydrate

GE3023-500 500
EUR 23.8

EDTA Disodium Salt Dihydrate

40500012-1 500 g
EUR 53.99

EDTA Disodium Salt Dihydrate

40500012-2 1 kg
EUR 89.15

EDTA Disodium Salt Dihydrate

40500012-3 2.5 kg
EUR 187.43

EDTA Disodium Salt Dihydrate

40500012-4 5 kg
EUR 319.37

EDTA Disodium Salt Dihydrate

40500012-5 10 kg
EUR 621.34

EDTA, Disodium Salt, Dihydrate

A2503-1KG 1KG
EUR 46.2
Description: Biotechnology

EDTA, Disodium Salt, Dihydrate

A2503-500G 500G
EUR 26.4
Description: Biotechnology

EDTA, Disodium Salt, Dihydrate

A2503-5KG 5KG
EUR 189.2
Description: Biotechnology

EDTA Disodium Salt 0.02m (0.04n)

ED20021 1L
EUR 157.2

EDTA Disodium Salt Dihydrate 0.1M

40500039-1 500 mL
EUR 20.55

EDTA Disodium Salt Dihydrate 0.1M

40500039-2 1 L
EUR 44.87

EDTA Disodium Salt Dihydrate 0.1M

40500039-3 4 L
EUR 97.31

EDTA Disodium Salt Dihydrate 0.057M

40500040-1 500 mL
EUR 15.48

EDTA Disodium Salt Dihydrate 0.057M

40500040-2 1 L
EUR 34.73

EDTA Disodium Salt Dihydrate 0.057M

40500040-3 4 L
EUR 90.31

EDTA Disodium Salt Dihydrate 0.05M

40500041-1 500 mL
EUR 14.05

EDTA Disodium Salt Dihydrate 0.05M

40500041-2 1 L
EUR 31.88

EDTA Disodium Salt Dihydrate 0.05M

40500041-3 4 L
EUR 90.31

EDTA zinc (II), disodium salt

EB6666 100g
EUR 77.75

EDTA copper(II) disodium salt

EB0434 250g
EUR 100.72

EDTA disodium zinc salt hydrate

GX3802-100G 100 g
EUR 64.8

EDTA disodium zinc salt hydrate

GX3802-250G 250 g
EUR 90

EDTA disodium zinc salt hydrate

GX3802-25G 25 g
EUR 51.6

EDTA disodium zinc salt hydrate

GX3802-500G 500 g
EUR 132

EDTA disodium zinc salt hydrate

GX3802-100 100
EUR 23.8

EDTA disodium zinc salt hydrate

GX3802-25 25
EUR 13.9

EDTA disodium zinc salt hydrate

GX3802-250 250
EUR 44.3

EDTA disodium zinc salt hydrate

GX3802-500 500
EUR 79.1

EDTA disodium and monocalcium salt

EK014P2 500g
EUR 115.33

EDTA disodium and monomagnesium salt

EB0435 500g
EUR 133.08

Volumetric Sol EDTA (DiSodium Salt) 0.01785M (0.0357N)

ED2003571 1L
EUR 112.28

EDTA magnesium disodium salt hydrate

GE3956-100G 100 g
EUR 79.2

EDTA magnesium disodium salt hydrate

GE3956-1KG 1 kg
EUR 294

EDTA magnesium disodium salt hydrate

GE3956-250G 250 g
EUR 122.4

EDTA magnesium disodium salt hydrate

GE3956-25G 25 g
EUR 54

EDTA magnesium disodium salt hydrate

GE3956-500G 500 g
EUR 184.8

EDTA manganese disodium salt hydrate

GX6009-100G 100 g
EUR 122.4

EDTA manganese disodium salt hydrate

GX6009-250G 250 g
EUR 208.8

EDTA manganese disodium salt hydrate

GX6009-25G 25 g
EUR 69.6

EDTA manganese disodium salt hydrate

GX6009-500G 500 g
EUR 322.8

EDTA magnesium disodium salt hydrate

GE3956-1 1
EUR 213.7

EDTA magnesium disodium salt hydrate

GE3956-100 100
EUR 35.5

EDTA magnesium disodium salt hydrate

GE3956-25 25
EUR 16.4

EDTA magnesium disodium salt hydrate

GE3956-250 250
EUR 71.1

EDTA magnesium disodium salt hydrate

GE3956-500 500
EUR 122.6

EDTA manganese disodium salt hydrate

GX6009-100 100
EUR 71.1

EDTA manganese disodium salt hydrate

GX6009-25 25
EUR 27.8

EDTA manganese disodium salt hydrate

GX6009-250 250
EUR 142.4

EDTA manganese disodium salt hydrate

GX6009-500 500
EUR 237.2

Volumetric Sol EDTA (DiSodium Salt) 0.002M (0.004N)

ED200021 1L
EUR 54

Volumetric Sol EDTA (DiSodium Salt) 0.002M (0.004N)

ED200025 5L
EUR 151.45

Volumetric Sol EDTA (DiSodium Salt) 0.025M (0.05N)

ED200251 1L
EUR 304.8

Volumetric Sol EDTA (DiSodium Salt) 0.027M (0.054N)

EDB200271 1L
EUR 35.64

Volumetric Sol EDTA (DiSodium Salt) 0.1M (0.2N)

ED2011 1L
EUR 37.2

Volumetric Sol EDTA (DiSodium Salt) 0.1M (0.2N)

ED2015 5L
EUR 116.4

Volumetric Sol EDTA (DiSodium Salt) 0.1M (0.2N)

EDB20110 10L
EUR 210

Volumetric Sol EDTA (DiSodium Salt) 0.01M (0.02N)

ED20011 1L
EUR 27.6

Volumetric Sol EDTA (DiSodium Salt) 0.01M (0.02N)

ED20015 5L
EUR 73.2

Volumetric Sol EDTA (DiSodium Salt) 0.05M (0.10N)

ED20051 1L
EUR 61.2

Volumetric Sol EDTA (DiSodium Salt) 0.01M (0.02N)

EDB200110 10L
EUR 144.92

EDTA disodium salt dihydrate, 99%, Ph. Eur. grade

GX8832-1 1
EUR 67.2

EDTA disodium salt dihydrate, 99%, Ph. Eur. grade

GX8832-5 5
EUR 237.2

EDTA disodium salt dihydrate, 99%, Ph. Eur. grade

GX8832-500 500
EUR 39.4

Volumetric Sol EDTA (DiSodium Salt) 0.027M (Bag In Box)

EDB20027 10L
EUR 264

Volumetric Sol EDTA (DiSodium Salt) 0.1M (Bag In Box)

EDB20105 5L
EUR 175.2

EDTA, Disodium Dihydrate Salt Ultra Pure Grade

20-147 500g/Unit
EUR 366

1 Amp Conc EDTA (DiSodium salt) to make 1L 0.05M

ETC0051L EACH
EUR 35.64

1 Amp Conc EDTA (DiSodium salt) to make 1L 0.01M

EDC0011L EACH
EUR 35.64

EDTA calcium disodium salt dihydrate, BP, Ph. Eur., USP grade

GE8581-1KG 1 kg
EUR 241.2